Komori
Mochida Pharmaceutical (4534) · InitiativeCited as achieved

Lowering the Investment Unit and Expanding the Investor Base Through a Stock Split

First written in FY2019-Q3. 4 of 6 entries say "Cited as achieved", first in FY2020-Q1. Latest entry: FY2021.

6entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019-Q3Cited as achievedFY2020-Q1 – FY20212019: 320192020: 220202021: 12021
Same theme, other companies
Stock SplitA theme 943 companies write about · 0 as a headwind · 932 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 956 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2021Cited as achievedAnnual report

    「The Company conducted a 2-for-1 share split effective 1 April 2019.」

    The share split effective 1 April 2019 is being restated as a completed initiative.
  2. FY2020Cited as achievedAnnual report

    「The Company conducted a 2-for-1 share split effective 1 April 2019.」

    The share split effective 1 April 2019 is being restated as a completed initiative.
  3. FY2020-Q3Cited as achievedAnnual report

    「The Company conducted a 2-for-1 share split effective 1 April 2019.」

    The 2-for-1 share split effective 1 April 2019 is being restated as a completed initiative.
  4. FY2020-Q1Cited as achievedAnnual report

    「The Company conducted a 2-for-1 share split effective 1 April 2019.」

    The 2-for-1 share split effective 1 April 2019 is being restated as a completed initiative.
  5. FY2019AchievedAnnual report

    「The Company conducted a 2-for-1 split of common shares effective 1 April 2019.」

    The share split resolved on 8 February 2019 was implemented effective 1 April 2019. The purpose was to improve share liquidity and expand the investor base by lowering the amount required per investment unit.
  6. FY2019-Q3First statedAnnual report

    「At a meeting of the Board of Directors held on 8 February 2019, the Company resolved to conduct a share split and make partial amendments to the Articles of Incorporation in connection with the share split, as described below. The purpose is to improve the liquidity of the Company’s shares and expand its investor base by lowering the amount required per investment unit. With 31 March 2019 (Sunday) as the record date, the Company will conduct a 2-for-1 split of common shares held by shareholders listed or recorded in the final shareholder register on that date.」

    The Company has stated for the first time its plan, resolved by the Board of Directors on 8 February 2019, to conduct a 2-for-1 share split with 31 March 2019 as the record date and 1 April 2019 as the effective date. The purpose is to improve share liquidity and expand the investor base by lowering the amount required per investment unit.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Mochida Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.